1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Maryland >
  6. Samaritan Pharmaceuticals Acquires Metastatin Pharmaceuticals

M&A Deal Summary

Samaritan Pharmaceuticals Acquires Metastatin Pharmaceuticals

On March 1, 2007, Samaritan Pharmaceuticals acquired life science company Metastatin Pharmaceuticals

Acquisition Highlights
  • This is Samaritan Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Samaritan Pharmaceuticals’ 1st transaction in the United States.
  • This is Samaritan Pharmaceuticals’ 1st transaction in Maryland.

M&A Deal Summary
Date 2007-03-01
Target Metastatin Pharmaceuticals
Sector Life Science
Buyer(s) Samaritan Pharmaceuticals
Deal Type Add-on Acquisition

Target

Metastatin Pharmaceuticals

Bethesda, Maryland, United States
Metastatin Pharmaceuticals, Inc. is a biopharmaceutical company focused on molecularly targeted Cancer drugs to control tumor progression and metastasis.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Samaritan Pharmaceuticals

Las Vegas, Nevada, United States
Category Company
Founded 1994
Sector Life Science
Employees16
DESCRIPTION

Samaritan Pharmaceuticals, Inc. is a small-cap Biotech, driven to discover, develop and commercialize innovative therapeutics' for AIDS, Alzheimer's, Cancer and Heart disease patients.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Maryland M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2007 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal